Powered by

Novartis data confirm rapid response and high efficacy of Cosentyx(R) in psoriasis patients for first time in China

Mar 04, 2019 - Thomson Reuters ONE

Novartis International AG / Novartis data confirm rapid response and high efficacy of Cosentyx(R) in psoriasis patients for first time in China . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement.

- Phase III study shows close to 9/10 patients who received Cosentyx(R) 300mg achieved clear or almost clear skin during the first 16 weeks of treatment (87%), with rapid onset of relief seen as early as week 3[1]

- Results ...